NORFLOXACIN SUSCEPTIBILITY POWDER— 510(k) K864442

Substantially Equivalent

Merck, Sharp & Dohme

FDA 510(k) clearance K864442 for NORFLOXACIN SUSCEPTIBILITY POWDER, Substantially Equivalent on 1986-12-11. Applicant: Merck, Sharp & Dohme.

Clearance details

Applicant: Merck, Sharp & Dohme
Product code: Code JTT
Advisory panel: Microbiology
Date received: 1986-11-12
Decision date: 1986-12-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: West Point, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.